期刊文献+

降钙素原测定对重症感染性疾病的预后判断价值 被引量:6

下载PDF
导出
摘要 目的:前瞻性研究血清降钙素原测定在ICU感染性疾病中的意义。方法:192例ICU危重病患者,在入院时、1天、2天、4天、6天及8天分别采集静脉血3mL,检测患者血清降钙素原及入院同时采静脉血检测血培养。研究起点从患者入住ICU时,研究终点为患者转科、出院或者死亡。结果:(1)192例ICU危重病患者分为死亡组和存活组。死亡组67例,降钙素原浓度为5.91±2.52ng/mL;存活组125例,降钙素原浓度为1.67±0.84 ng/mL,两组比较差异有统计学意义(P<0.01)。(2)血清降钙素原与APACHEⅡ评分相关性:死亡组随降钙素原浓度的增加,APACHEⅡ评分亦增加,两者呈明显正相关(r=0.985,P<0.01);存活组随降钙素原浓度的增加,APACHEⅡ评分无明显变化,两者无相关,差异无统计学意义(r=0.113,P>0.05)。结论:血清降钙素原能反映ICU感染性疾病患者严重程度及对患者的预后判断有一定的临床意义。
出处 《交通医学》 2013年第1期58-60,共3页 Medical Journal of Communications
  • 相关文献

参考文献9

  • 1保勇,史梦,喻华,叶兰.检测血清降钙素原对感染性疾病及脓毒症的诊断价值[J].实用医院临床杂志,2012,9(1):94-96. 被引量:60
  • 2Pettila V, Hynninen M, Takkumem O, et al. Predictive value of procalciton in and interleukin 6 in critically ill patientswith suspected sepsis [J ]. Intensive Care Med, 2002,28 (9): 1220-1225.
  • 3Bone RC, Balk RA, Cerra FB, et al. ACCP/SCCM consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies [J]. Chest, 2002, 101(8): 1644-1655.
  • 4尔启东,黄涛.降钙素原的临床应用新进展[J].哈尔滨医药,2012,32(1):57-57. 被引量:14
  • 5宋秀琴,时兢,谢卫星,陆荣国,王烨,衡军锋.降钙素原在危重病人败血症诊断中的应用[J].中国急救医学,2003,23(9):653-654. 被引量:9
  • 6杜斌,陈德昌,潘家绮,李毅.降钙素原与白介素-6的相关性优于传统的炎症指标[J].中国危重病急救医学,2002,14(8):474-477. 被引量:145
  • 7Meisner M, Tschaikowsky K, Palmaers T, et al. Comparison of procalcitonin(PCT) and C-reactive protein(CRP) palsma concentrations at different SOFA scores during the course of sepsis and MODS [J].Crit Care,1999,3( 1 ):45-55.
  • 8Van Rossum AM, Wulkan RW ,Qudesluys-murphy AM.Pro- calcitonin as an early marker of infection in neonates and children[J]. Lancet Infect Dis , 2004,4(10) :620-630.
  • 9Schuetz P, Christ-Crain M, Thomann R, et al. Effect of pro- calcitonin-based guidelines vs standard guidelines on an- tibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial[J]. JAMA, 2009,302(10):1059- 1066.

二级参考文献26

  • 1赵玉玲.降钙素原对脓毒症早期诊断的临床意义[J].检验医学,2006,21(4):431-431. 被引量:37
  • 2Sessler CN, ShepherdW. New concepts in sepsis [ J ] . Curr Opi Crit Care ,2002,8 ( 5 ) :465-472.
  • 3Schwarz S, Bertram M, Schwab S, et al. Serum proca lciton in levels in bacterial and abacterialm en ingit is[J]. C rit Care M ed,2000, 28 (6) :1828-1832.
  • 4Membersof the ACCP Consensus Conference Committee. Crit Care Med, 1992,271:226-233.
  • 5Pett ila V,Hynninen M,Takkunen O,et al. Predict ire value of procalciton in and interleuk in 6 in crit ically ill patients with suspec- ted sepsis [J]. Intensive Care Med,2002,25 ( 9 ) :1220-1225.
  • 6Bohuon C. Abrief history of procalcit on in[J]. Intensive Care Med ,2000,26 : 146-147.
  • 7Assicot M , Gendrel D, Carsin H, et al . High serum procal cit onin concent rat ionsin pat ien ts w ith s eps is and infect ion [J]. Lancet ,1999,341:515 -551.
  • 8Assicot M , Gendrel D, Car sin H, et al. High serum procal cit onin concent rat ionsin pat ien ts with s eps is and infect ion [ J ]. Lancet ,1999,341:515 -551.
  • 9Tsokos M, Reichelt U, Nierhaus A, et al. Serum procalcit onin (PCT) :a valuable biochemical parameter for the post mortem diagnosis of sepsis[J]. Int J Legal Med,2001,114(4-5) :237-243.
  • 10Giamarellos-Boutboulis EJ, Mega A, Grecka P, et al. Procatcitonin: a marker to clearly differentiate systemic inflammatory respones syn- drome and sepsis in the critically ill patient [J]. Intensive Care Med,2002,28:13-51.

共引文献223

同被引文献60

引证文献6

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部